125 related articles for article (PubMed ID: 34531543)
1. Targeted minor histocompatibility antigen typing to estimate graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Nie D; Zhang J; Liu L; Li X; Wang J; Wang J; Zhang W; Chen J; Zhou X; Tan Y; Liu H; Tian W
Bone Marrow Transplant; 2021 Dec; 56(12):3024-3028. PubMed ID: 34531543
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.
Martin PJ; Levine DM; Storer BE; Warren EH; Zheng X; Nelson SC; Smith AG; Mortensen BK; Hansen JA
Blood; 2017 Feb; 129(6):791-798. PubMed ID: 27872059
[TBL] [Abstract][Full Text] [Related]
3. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
4. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
5. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
Weisdorf DJ; Nelson G; Lee SJ; Haagenson M; Spellman S; Antin JH; Bolwell B; Cahn JY; Cervantes F; Copelan E; Gale R; Gratwohl A; Khoury HJ; McCarthy P; Marks DI; Szer J; Woolfrey A; Cortes-Franco J; Horowitz MM; Arora M;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1475-8. PubMed ID: 19822308
[TBL] [Abstract][Full Text] [Related]
6. CD31 mismatching affects marrow transplantation outcome.
Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
[TBL] [Abstract][Full Text] [Related]
7. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.
Lazaryan A; Weisdorf DJ; DeFor T; Brunstein CG; MacMillan ML; Bejanyan N; Holtan S; Blazar BR; Wagner JE; Arora M
Biol Blood Marrow Transplant; 2016 Jan; 22(1):134-40. PubMed ID: 26365153
[TBL] [Abstract][Full Text] [Related]
9. Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation.
Story CM; Wang T; Bhatt VR; Battiwalla M; Badawy SM; Kamoun M; Gragert L; Brown V; Baxter-Lowe LA; Marsh SGE; Gadalla SM; Schetelig J; Mytilineos J; Miklos D; Waller EK; Kuxhausen M; Spellman S; Lee S; Paczesny S; Lansford JL; Vincent BG; Riches ML; Armistead PM;
Transplant Cell Ther; 2021 Jul; 27(7):591-599. PubMed ID: 33882342
[TBL] [Abstract][Full Text] [Related]
10. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
[TBL] [Abstract][Full Text] [Related]
11. Minor histocompatibility antigens as determinants for graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Turpeinen H; Ojala PJ; Ojala K; Miettinen M; Volin L; Partanen J
Int J Immunogenet; 2013 Dec; 40(6):495-501. PubMed ID: 23480177
[TBL] [Abstract][Full Text] [Related]
12. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling.
El-Chennawi FA; Kamel HA; Mosaad YM; El-Sherbini SM; El-Billey NA
Hematology; 2006 Aug; 11(4):227-34. PubMed ID: 17178660
[TBL] [Abstract][Full Text] [Related]
13. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation.
Tseng LH; Lin MT; Hansen JA; Gooley T; Pei J; Smith AG; Martin EG; Petersdorf EW; Martin PJ
Blood; 1999 Oct; 94(8):2911-4. PubMed ID: 10515896
[TBL] [Abstract][Full Text] [Related]
14. Mapping of susceptibility and protective loci for acute GVHD in unrelated HLA-matched bone marrow transplantation donors and recipients using 155 microsatellite markers on chromosome 22.
Kikuchi T; Naruse TK; Onizuka M; Li S; Kimura T; Oka A; Morishima Y; Kulski JK; Ichimiya S; Sato N; Inoko H
Immunogenetics; 2007 Feb; 59(2):99-108. PubMed ID: 17200870
[TBL] [Abstract][Full Text] [Related]
15. Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT.
Ritari J; Hyvärinen K; Koskela S; Niittyvuopio R; Nihtinen A; Salmenniemi U; Putkonen M; Volin L; Kwan T; Pastinen T; Itälä-Remes M; Partanen J
Front Immunol; 2019; 10():1625. PubMed ID: 31379830
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
Li S; Kawata H; Katsuyama Y; Ota M; Morishima Y; Mano S; Kulski JK; Naruse T; Inoko H
Tissue Antigens; 2004 Apr; 63(4):362-8. PubMed ID: 15009808
[TBL] [Abstract][Full Text] [Related]
17. Recipient cytokine genotypes for TNF-alpha and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GVHD in unrelated cord blood transplantation: a retrospective analysis.
Kögler G; Middleton PG; Wilke M; Rocha V; Esendam B; Enczmann J; Wernet P; Gluckman E; Querol S; Lecchi L; Goulmy E; Dickinson AM
Transplantation; 2002 Oct; 74(8):1167-75. PubMed ID: 12438965
[TBL] [Abstract][Full Text] [Related]
18. Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantation.
Jadi O; Tang H; Olsen K; Vensko S; Zhu Q; Wang Y; Haiman CA; Pooler L; Sheng X; Brock G; Webb A; Pasquini MC; McCarthy PL; Spellman SR; Hahn T; Vincent B; Armistead P; Sucheston-Campbell LE
Am J Hematol; 2023 Jun; 98(6):940-950. PubMed ID: 37052167
[TBL] [Abstract][Full Text] [Related]
19. Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study.
Balduzzi A; Dalle JH; Wachowiak J; Yaniv I; Yesilipek A; Sedlacek P; Bierings M; Ifversen M; Sufliarska S; Kalwak K; Lankester A; Toporski J; Di Maio L; Glogova E; Poetschger U; Peters C
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2197-2210. PubMed ID: 31319153
[TBL] [Abstract][Full Text] [Related]
20. Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.
Spellman S; Warden MB; Haagenson M; Pietz BC; Goulmy E; Warren EH; Wang T; Ellis TM
Biol Blood Marrow Transplant; 2009 Jul; 15(7):856-63. PubMed ID: 19539218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
